What AI says about Ekterly

EKTERLY® (sebetralstat) is the first and only oral on-demand therapy for treating hereditary angioedema (HAE) attacks in adults and children aged 12 and older. It allows patients to treat attacks anywhere without needles, pain, or preparation, and is supported by a patient support program.